Organic Growth of Current Portfolio
Drive organic growth by leveraging our existing product portfolio.
We continuously look to license or acquire new products and solutions aimed at addressing the essential needs of consumers, patients and health care partners, leveraging our North American sales force and infrastructure.
We operate through two segments: Medexus Pharma Canada and Medexus Pharma USA. We have excellent coverage of rheumatologists in the USA and Canada, plus coverage of pediatrics, allergy and primary care in Canada.View Divisions
Our highly diversified product portfolio and growing pipeline features several leading products such as Rasuvo, Metoject, Rupall, Treosulfan, and Gliolan. The majority of our portfolio is in growth phase.View Product Portfolio